Cargando…
Are Myths and Preconceptions Preventing Us from Applying Ionic Liquid Forms of Antiviral Medicines to the Current Health Crisis?
At the moment, there are no U.S. Food and Drug Administration (U.S. FDA)-approved drugs for the treatment of COVID-19, although several antiviral drugs are available for repurposing. Many of these drugs suffer from polymorphic transformations with changes in the drug’s safety and efficacy; many are...
Autores principales: | Shamshina, Julia L., Rogers, Robin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503643/ https://www.ncbi.nlm.nih.gov/pubmed/32825444 http://dx.doi.org/10.3390/ijms21176002 |
Ejemplares similares
-
Use of Ionic Liquids in Chitin Biorefinery: A Systematic Review
por: Shamshina, Julia L., et al.
Publicado: (2020) -
Renewable Biopolymers Combined with Ionic Liquids for the Next Generation of Supercapacitor Materials
por: Shamshina, Julia L., et al.
Publicado: (2023) -
Acyclovir as an Ionic Liquid Cation or Anion Can Improve
Aqueous Solubility
por: Shamshina, Julia L., et al.
Publicado: (2017) -
Deproteinization of Chitin Extracted with the Help of Ionic Liquids
por: Lyon, Douglas R., et al.
Publicado: (2022) -
Ionic Liquids as Tools to Incorporate Pharmaceutical Ingredients into Biopolymer-Based Drug Delivery Systems
por: Berton, Paula, et al.
Publicado: (2023)